Literature DB >> 3371720

Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?

P R Gibson1, E van de Pol, P J Barratt, W F Doe.   

Abstract

The leakiness of the cell membranes of colonic epithelial cells isolated by the collagenase/Dispase technique from normal or diseased colons was assessed in a 4 h 51Cr release assay. Cells from normal, adenoma bearing or cancer bearing colons showed 51Cr release of 8% or less in almost all of 46 cell populations tested. In contrast, cells from mucosa affected by ulcerative colitis [11.9 (4.3%) n = 23] or Crohn's disease [8.4 (2.7%) n = 18] released significantly more 51Cr than the non-inflamed groups. Values are expressed as mean (SD). Overall, release values were greater in ulcerative colitis than Crohn's disease (p less than 0.01). In Crohn's disease, cells obtained from histologically inflamed mucosa released significantly more 51Cr [9.7 (2.5%) n = 11] than those from non-inflamed mucosa [6.4 (1.5%) n = 7, p less than 0.02] whereas, in ulcerative colitis, abnormal release values were found in 8 of 13 cell populations isolated from mucosa showing no histological evidence of active disease. In five patients with distal ulcerative colitis, cells from mucosa not apparently involved demonstrated normal 51Cr release in four of five studies despite abnormal release from cells from involved mucosa suggesting that a diffuse abnormality of the colonic epithelial cell is not usually present. These data indicate that chronic mucosal inflammation per se is associated with abnormalities of the colonic epithelial cell but that, in ulcerative colitis, the abnormality remains in many patients with quiescent disease. Identification of the local factors responsible for such an abnormality may contribute to an understanding of the pathogenesis of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371720      PMCID: PMC1433529          DOI: 10.1136/gut.29.4.516

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Antibody-induced destruction of colon antigen-coated chicken erythrocytes by normal human lymphocytes.

Authors:  H E Carlsson; S Hammarström; M Lanteli; P Perlmann
Journal:  Eur J Immunol       Date:  1971-08       Impact factor: 5.532

2.  Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis.

Authors:  G L Eastwood; J S Trier
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

3.  Inflammatory bowel disease. The role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cells.

Authors:  R G Shorter; K A Huizenga; R J Spencer; S K Guy
Journal:  Am J Dig Dis       Date:  1972-08

4.  Cell renewal in the human rectum. In vitro autoradiographic study on active ulcerative colitis.

Authors:  H Bleiberg; P Mainguet; P Galand; J Chretien; N Dupont-Mairesse
Journal:  Gastroenterology       Date:  1970-06       Impact factor: 22.682

5.  Cytotoxicity of mononuclear cells for autologous colonic epithelial cells in colonic diseases.

Authors:  R G Shorter; D B McGill; R C Bahn
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

6.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Small intestinal injury in the graft versus host reaction: an innocent bystander phenomenon.

Authors:  C O Elson; R W Reilly; I H Rosenberg
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

8.  Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis.

Authors:  D K Podolsky; K J Isselbacher
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

9.  Rate and pattern of epithelial cell proliferation in ulcerative colitis.

Authors:  E P Serafini; A P Kirk; T J Chambers
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

10.  Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.

Authors:  D S Rampton; G E Sladen; L J Youlten
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

View more
  11 in total

1.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

Review 2.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Expression of apoptotic epithelial cells in biopsy specimens of patients with colitis.

Authors:  Kazuko Shichijo; Takeshi Shin; Chun-Yang Wen; Toshiyuki Nakayama; Masahiro Nakashima; Alipov Gabit Kaimovich; Mutsumi Matsuyama; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 4.  Metabolism of large bowel mucosa in health and disease.

Authors:  G Latella; R Caprilli
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

5.  Bax is downregulated in inflamed colonic mucosa of ulcerative colitis.

Authors:  M Iimura; T Nakamura; S Shinozaki; B Iizuka; Y Inoue; S Suzuki; N Hayashi
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

6.  Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease.

Authors:  P R Gibson; E van de Pol; W Pullman; W F Doe
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

7.  Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.

Authors:  S Almer; L Franzén; G Olaison; K Smedh; M Ström
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

8.  Cell associated urokinase activity and colonic epithelial cells in health and disease.

Authors:  P R Gibson; E van de Pol; W F Doe
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

9.  Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation.

Authors:  P Gibson; M Lichtenstein; N Salehi; G Hebbard; J Andrews
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

10.  Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis.

Authors:  Philip J Smith; Adam P Levine; Jenny Dunne; Paul Guilhamon; Mark Turmaine; Gavin W Sewell; Nuala R OʼShea; Roser Vega; Jennifer C Paterson; Dahmane Oukrif; Stephan Beck; Stuart L Bloom; Marco Novelli; Manuel Rodriguez-Justo; Andrew M Smith; Anthony W Segal
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.